|
|
Prepublished online as a Blood First Edition Paper on September 26, 2002; DOI 10.1182/blood-2002-05-1586.

Submitted May 29, 2002
Accepted September 3, 2002
Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases
Kent W Christopherson, Antoinette F Hood, Jeffrey B Travers, Heather Ramsey, and Robert A Hromas*
Department of Microbiology & Immunology and the Walther Oncology Center, Indiana University Medical Center, Indianapolis, IN, USA
Department of Dermatology and the Wells Center for Pediatric Research, Indiana University Medical Center, Indianapolis, IN, USA
Division of Hematology/Oncology and Walther Oncology Center, Indiana University Medical Center, Indianapolis, IN, USA
* Corresponding author; email: rhromas{at}iupui.edu.
The signals which mediate T-cell infiltration during T-cell auto-immune diseases are poorly understood. The chemokine CCL21 (originally isolated by us and others as Exodus-2/6Ckine/SLC/TCA4) is highly potent and highly specific for attracting T-cell migration. However, it is thought to be expressed only in secondary lymphoid organs, directing naive T-cells to areas of antigen presentation. It is not thought to play a role in T-cell effector function during a normal immune response. In this study we tested the expression of T-cell chemokines and their receptors during T-cell auto-immune infiltrative skin diseases. Using immunohistology it was found that the expression of CCL21 but not CCL19 or 20 was highly induced in endothelial cells of T-cell auto-immune diseases. The receptor for CCL21, CCR7, was also found to be highly expressed on the infiltrating T-cells, the majority of which expressed the memory CD45Ro phenotype. These data imply that the usual loss of CCL21 responsiveness in the normal development of memory T-cell effector function does not hold for auto-immune skin diseases.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. K. Damas, C. Smith, E. Oie, B. Fevang, B. Halvorsen, T. Waehre, A. Boullier, U. Breland, A. Yndestad, O. Ovchinnikova, et al.
Enhanced Expression of the Homeostatic Chemokines CCL19 and CCL21 in Clinical and Experimental Atherosclerosis: Possible Pathogenic Role in Plaque Destabilization
Arterioscler Thromb Vasc Biol,
March 1, 2007;
27(3):
614 - 620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Raine, P. Zaccone, P. Mastroeni, and A. Cooke
Salmonella typhimurium Infection in Nonobese Diabetic Mice Generates Immunomodulatory Dendritic Cells Able to Prevent Type 1 Diabetes
J. Immunol.,
August 15, 2006;
177(4):
2224 - 2233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Tabibiazar, R. A. Wagner, A. Deng, P. S. Tsao, and T. Quertermous
Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis in mice
Physiol Genomics,
April 13, 2006;
25(2):
194 - 202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Liao, Y. Ke, W.-H. Shao, B. Haribabu, H. J. Kaplan, D. Sun, and H. Shao
Blockade of the interaction of leukotriene b4 with its receptor prevents development of autoimmune uveitis.
Invest. Ophthalmol. Vis. Sci.,
April 1, 2006;
47(4):
1543 - 1549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Middel, D Raddatz, B Gunawan, F Haller, and H-J Radzun
Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism
Gut,
February 1, 2006;
55(2):
220 - 227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Carriere, R. Colisson, C. Jiguet-Jiglaire, E. Bellard, G. Bouche, T. Al Saati, F. Amalric, J.-P. Girard, and C. M'Rini
Cancer Cells Regulate Lymphocyte Recruitment and Leukocyte-Endothelium Interactions in the Tumor-Draining Lymph Node
Cancer Res.,
December 15, 2005;
65(24):
11639 - 11648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Humphreys, L. A. Baldridge, S. D. Billings, J. J. Campbell, and S. M. Spinola
Trafficking Pathways and Characterization of CD4 and CD8 Cells Recruited to the Skin of Humans Experimentally Infected with Haemophilus ducreyi
Infect. Immun.,
July 1, 2005;
73(7):
3896 - 3902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. VALBUENA and D. H. WALKER
EFFECT OF BLOCKING THE CXCL9/10-CXCR3 CHEMOKINE SYSTEM IN THE OUTCOME OF ENDOTHELIAL-TARGET RICKETTSIAL INFECTIONS
Am J Trop Med Hyg,
October 1, 2004;
71(4):
393 - 399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-P. Armengol, C. B. Cardoso-Schmidt, M. Fernandez, X. Ferrer, R. Pujol-Borrell, and M. Juan
Chemokines Determine Local Lymphoneogenesis and a Reduction of Circulating CXCR4+ T and CCR7 B and T Lymphocytes in Thyroid Autoimmune Diseases
J. Immunol.,
June 15, 2003;
170(12):
6320 - 6328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Weninger, H. S. Carlsen, M. Goodarzi, F. Moazed, M. A. Crowley, E. S. Baekkevold, L. L. Cavanagh, and U. H. von Andrian
Naive T Cell Recruitment to Nonlymphoid Tissues: A Role for Endothelium-Expressed CC Chemokine Ligand 21 in Autoimmune Disease and Lymphoid Neogenesis
J. Immunol.,
May 1, 2003;
170(9):
4638 - 4648.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|